Michigan Biomedical Venture Fund

Overview

The Michigan Biomedical Venture Fund (MBVF) is a venture capital fund that invests in early-stage biomedical companies utilizing University of Michigan (U-M) licensed intellectual property. Established in April 2016, MBVF is a collaborative effort between the U-M Medical School's Fast Forward Medical Innovation (FFMI) program and the College of Engineering's Center for Entrepreneurship (CFE). The fund focuses on sectors such as therapeutics, medical devices, diagnostics, and health IT, aiming to bridge the gap between research and commercialization by providing seed and pre-seed capital to nascent biomedical startups. MBVF's investment strategy centers on supporting startups that are based on U-M technologies, fostering innovation within the university's ecosystem. The fund operates as an evergreen entity, meaning that returns from successful investments are reinvested into new ventures, creating a sustainable cycle of innovation and economic impact. This approach not only advances medical technologies but also contributes to the economic development of Michigan by nurturing high-growth companies. Since its inception, MBVF has been instrumental in launching and scaling numerous startups, demonstrating a strong track record in translating academic research into viable commercial products. The fund's philosophy emphasizes a patient, risk-tolerant approach to early-stage investing, recognizing the long-term nature of biomedical innovation and the importance of supporting entrepreneurs through the complex journey from concept to market.